Inovio Pharmaceuticals, Inc. (INO) SEC filings
INO SEC filings moved a median of -2.59% by the close. INO SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the INO overview →
54 measured INO SEC filing events.
Where these INO SEC filings landedvs 54 measured INO SEC filing reactions
| Middle 50% of INO SEC filing reactions | -6.24% to +0.57% |
|---|---|
| Median reaction (to close) | -2.59% |
| Measured reactions | 54 |
Point-in-time · zero look-ahead
Half of the 54 INO SEC filing events with a measured close landed between -6.24% and +0.57%; 28% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 8-K INOVIO PHARMACEUTICALS, For: Oct 06 | SEC filing · Form 8-K | +0.20% | +3.13% | |
| Form 10-Q INOVIO PHARMACEUTICALS, For: Jun 30 | SEC filing · Form 10-Q | +3.46% | +11.12% | |
| Form 8-K INOVIO PHARMACEUTICALS, For: Aug 12 | SEC filing · Form 8-K | +3.46% | +11.12% | |
| Form 8-K INOVIO PHARMACEUTICALS, For: Jul 29 | SEC filing · Form 8-K | +0.43% | +4.15% | |
| Form 8-K INOVIO PHARMACEUTICALS, For: Jul 29 | SEC filing · Form 8-K | -10.95% | -10.14% | |
| Form EFFECT INOVIO PHARMACEUTICALS, | SEC filing · Form EFFECT | +0.87% | +0.87% | |
| Form S-3 INOVIO PHARMACEUTICALS, | SEC filing · Form S-3 | +0.33% | -4.13% | |
| Form S-8 INOVIO PHARMACEUTICALS, | SEC filing · Form S-8 | -4.38% | -8.03% | |
| Form 8-K INOVIO PHARMACEUTICALS, For: May 19 | SEC filing · Form 8-K | -1.20% | +6.40% | |
| Form 10-Q INOVIO PHARMACEUTICALS, For: Mar 31 | SEC filing · Form 10-Q | +1.94% | +5.43% | |
| Form 8-K INOVIO PHARMACEUTICALS, For: May 13 | SEC filing · Form 8-K | +1.94% | +5.43% | |
| Form DEF 14A INOVIO PHARMACEUTICALS, For: May 20 | SEC filing · Form DEF | -2.69% | -1.80% | |
| Form 8-K INOVIO PHARMACEUTICALS, For: Apr 02 | SEC filing · Form 8-K | -2.71% | -1.74% | |
| Form 8-K INOVIO PHARMACEUTICALS, For: Apr 01 | SEC filing · Form 8-K | -9.63% | -16.30% | |
| Form 10-K INOVIO PHARMACEUTICALS, For: Dec 31 | SEC filing · Form 10-K | +1.51% | -3.49% | |
| Form 8-K INOVIO PHARMACEUTICALS, For: Mar 12 | SEC filing · Form 8-K | +1.51% | -3.49% | |
| Form 8-K INOVIO PHARMACEUTICALS, For: Jan 27 | SEC filing · Form 8-K | +1.65% | +0.66% | |
| Form 8-K INOVIO PHARMACEUTICALS, For: Dec 29 | SEC filing · Form 8-K | -2.67% | -8.95% | |
| Form 8-K INOVIO PHARMACEUTICALS, For: Nov 11 | SEC filing · Form 8-K | +1.75% | -2.97% | |
| Form 10-Q INOVIO PHARMACEUTICALS, For: Sep 30 | SEC filing · Form 10-Q | -3.50% | +0.00% | |
| Form 8-K INOVIO PHARMACEUTICALS, For: Nov 10 | SEC filing · Form 8-K | -3.50% | +0.00% | |
| Form 10-Q INOVIO PHARMACEUTICALS, For: Jun 30 | SEC filing · Form 10-Q | +5.30% | +12.58% | |
| Form 8-K INOVIO PHARMACEUTICALS, For: Aug 12 | SEC filing · Form 8-K | +5.30% | +12.58% | |
| Form 8-K INOVIO PHARMACEUTICALS, For: Jul 02 | SEC filing · Form 8-K | -6.23% | -8.28% | |
| Form 8-K INOVIO PHARMACEUTICALS, For: May 20 | SEC filing · Form 8-K | +0.00% | -0.51% | |
| Form 10-Q INOVIO PHARMACEUTICALS, For: Mar 31 | SEC filing · Form 10-Q | +2.59% | -2.08% | |
| Form 8-K INOVIO PHARMACEUTICALS, For: May 13 | SEC filing · Form 8-K | +2.59% | -2.08% | |
| Form ARS INOVIO PHARMACEUTICALS, For: Dec 31 | SEC filing · Form ARS | -3.82% | -11.52% | |
| Form DEF 14A INOVIO PHARMACEUTICALS, For: May 20 | SEC filing · Form DEF | -3.82% | -11.52% | |
| Form 10-K INOVIO PHARMACEUTICALS, For: Dec 31 | SEC filing · Form 10-K | -1.87% | -6.22% | |
| Form 8-K INOVIO PHARMACEUTICALS, For: Mar 18 | SEC filing · Form 8-K | -1.87% | -6.22% | |
| Form 8-K INOVIO PHARMACEUTICALS, For: Dec 12 | SEC filing · Form 8-K | -3.96% | -10.42% | |
| Form 10-Q INOVIO PHARMACEUTICALS, For: Sep 30 | SEC filing · Form 10-Q | -2.28% | -12.78% | |
| Form 8-K INOVIO PHARMACEUTICALS, For: Nov 14 | SEC filing · Form 8-K | -2.28% | -12.78% | |
| Form 8-K INOVIO PHARMACEUTICALS, For: Aug 13 | SEC filing · Form 8-K | -2.58% | -3.07% | |
| Form 10-Q INOVIO PHARMACEUTICALS, For: Jun 30 | SEC filing · Form 10-Q | +1.53% | -0.71% | |
| Form 8-K INOVIO PHARMACEUTICALS, For: Aug 08 | SEC filing · Form 8-K | +1.53% | -0.71% | |
| Form 8-K INOVIO PHARMACEUTICALS, For: May 21 | SEC filing · Form 8-K | -1.48% | -1.08% | |
| Form 10-Q INOVIO PHARMACEUTICALS, For: Mar 31 | SEC filing · Form 10-Q | +2.28% | -3.63% | |
| Form 8-K INOVIO PHARMACEUTICALS, For: May 13 | SEC filing · Form 8-K | +2.28% | -3.63% | |
| Form 8-K INOVIO PHARMACEUTICALS, For: Apr 15 | SEC filing · Form 8-K | -3.64% | -7.27% | |
| Form ARS INOVIO PHARMACEUTICALS, For: Dec 31 | SEC filing · Form ARS | +5.37% | +14.84% | |
| Form DEF 14A INOVIO PHARMACEUTICALS, For: Dec 31 | SEC filing · Form DEF | +0.00% | -5.48% | |
| Form 10-K INOVIO PHARMACEUTICALS, For: Dec 31 | SEC filing · Form 10-K | -0.31% | -6.42% | |
| Form EFFECT INOVIO PHARMACEUTICALS, | SEC filing · Form EFFECT | -1.66% | -2.21% | |
| Form S-3/A INOVIO PHARMACEUTICALS, | SEC filing · Form S-3 | +0.00% | +0.32% | |
| Form 8-K INOVIO PHARMACEUTICALS, For: Jan 24 | SEC filing · Form 8-K | +3.06% | -10.48% | |
| Form 8-K INOVIO PHARMACEUTICALS, For: Jan 12 | SEC filing · Form 8-K | -4.10% | -1.84% | |
| Form DEF 14A INOVIO PHARMACEUTICALS, For: Jan 12 | SEC filing · Form DEF | -0.15% | -3.89% | |
| Form PRE 14A INOVIO PHARMACEUTICALS, For: Jan 12 | SEC filing · Form PRE | -1.83% | +2.44% | |
| Form 10-Q INOVIO PHARMACEUTICALS, For: Sep 30 | SEC filing · Form 10-Q | -6.00% | -6.24% | |
| Form 8-K INOVIO PHARMACEUTICALS, For: Nov 09 | SEC filing · Form 8-K | -6.00% | -6.24% | |
| Form S-3 INOVIO PHARMACEUTICALS, | SEC filing · Form S-3 | -6.00% | -6.24% | |
| Form 8-K INOVIO PHARMACEUTICALS, For: Nov 01 | SEC filing · Form 8-K | +0.70% | +2.07% |
Keep exploring
More INO: earnings → · analyst actions → · INO overview →
Other Healthcare names and their SEC filings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| OPHTHOTECH CORP COMMON (OPHT) | 660 | -0.20% | 43% |
| Gritstone bio, Inc. (GRTS) | 659 | -0.01% | 50% |
| VistaGen Therapeutics, Inc. (VTGN) | 658 | +0.16% | 52% |
| Quanterix Corporation (QTRX) | 657 | -0.21% | 46% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.